Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Developed by Danish drugmaker Novo Nordisk, and FDA-approved in 2017, Ozempic lowers blood sugar by helping the body make more insulin through weekly injections. Its main aim is to help adults who ...

Subscribe to our newsletter and stay updated on the latest developments and special offers!